June 30, 2020
891
103
25
14.37%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
11:00Now PlayingSupport our movement for better Journalism at our
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
Donate To Keep us sustainable
Or become a channel member
Ask a question, help the show!
Check out our cool Merch!
You can also Donate via Paypal: paypal.me/TYTNation
Download & Listen to the Podcast version of the show available here
#AroundTheNation #TYTNation #TYTNetwork
Subscribe to our channel for daily videos
Like Our Facebook Page!
Follow us on Twitter @ATNonTYT
Follow Jeff on Twitter: @JeffsPolitics
Sign up with our partner Microbinge
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.